IYH News and Press, iShares U.S. Healthcare From 02/15/24

2024-02-15 08:04:12 ET Summary Health Care Select Sector SPDR Fund is recommended as a buy due to its strong mix of holdings, low expense ratio, and noteworthy dividend yield. XLV has outperformed its peer health care ETFs in terms of one-year performance and has a relatively low ...

2024-02-07 01:53:00 ET Summary A sub-$3trn 2023 for M&A, but new year pipeline gives hope. Rising follow-on equity in 2023 signals latent appetite. Unstoppable debt capital markets hit $8.9trn for FY2023. By Lucille Jones, Senior Manager, Deals Intelligence and...

2024-01-31 04:36:00 ET Summary 2023 was characterized by narrow leadership and multiple expansions. While last year’s gains have led to headline valuations appearing stretched, there are many segments of the market that are not as aggressively priced. With the expectati...

2024-01-22 10:44:27 ET Summary Vanguard's Health Care ETF has slightly underperformed peer healthcare funds and risks underperforming looking forward due to its current mix of holdings. VHT is broadly diversified, resulting in a lower weight on top healthcare performers like Johns...

2024-01-20 00:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-19 08:00:00 ET Summary The healthcare sector is overvalued by 12.5% based on 11-year averages. Nevertheless, the healthcare providers industry shows a good value score. iShares U.S. Healthcare ETF is an unattractive alternative to XLV. We look at 10 healthcare stocks c...

2024-01-17 23:22:58 ET Summary The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to adjust drug prices in line with inflation, provid...

2024-01-16 04:50:00 ET Summary Why US banks could be poised for a rebound? Sectors primed for a pivot if the Fed cuts. The outlook for healthcare and real estate. The potential for interest rate cuts this year by the U.S. Federal Reserve is raising the outlook for ...

2024-01-15 12:40:00 ET Summary All decisions around investing, everything we're seeing everyone doing is now colored by the rate situation. Artificial intelligence is a constantly growing and transforming phenomenon. Unlike artificial intelligence, a lot of the most exciting a...

2024-01-14 03:40:00 ET Summary Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharma will be acquired by Johnson & Johnson for $2 billion. GSK plans to acquire Aiolos Bio, a San Francisco-London s...